These findings confirmed that SOD2‐Fer‐1@CVs not only inhibit M1 activation but also inhibit their capacity to induce endothelial dysfunction, underscoring their therapeutic potential in modulating macrophage‐endothelial crosstalk. This evidence concerns the gene SOD2 and endothelial dysfunction.